期刊文献+

羟氯喹对系统性红斑狼疮患者孕期血脂、同型半胱氨酸及心功能的影响 被引量:5

Effect of blood lipid,homocysteine and cardiac function with hydroxychloroquine on systemic lupus erythematosus patients during pregnancy
下载PDF
导出
摘要 (1)目的探讨羟氯喹对系统性红斑狼疮(SLE)患者孕期血脂、同型半胱氨酸(Hcy)及心功能的影响。(2)方法 61例SLE妊娠患者随机分成两组,其中观察组31例为羟氯喹加激素治疗,对照组30例采用单纯激素治疗,分析两组患者孕期血脂、Hcy及心功能的改变。(3)结果观察组总胆固醇(TC)、甘油三脂(TG)、低密度脂蛋白胆固醇(LDL-C)、高密度脂蛋白胆固醇(HDL-C)和Hcy均低于对照组,两组比较差异有统计学意义;血清Hcy、TC、TG、LDL-C与SLE疾病活动度(SLEDAI)评分呈正相关,血清Hcy水平与TC、TG、LDL-C呈正相关;心功能两组比较则无明显改变。(4)结论 SLE患者孕期使用羟氯喹可明显改善脂代谢,而对心功能则影响不大。因此认为SLE患者孕期使用羟氯喹是有益的,可有效改善糖脂代谢,降低SLEDAI评分和心脑血管疾病的发病风险。 Objective To explore the effect of blood lipid, homocysteine with hydroxychloroquine on systemic lupus erythematosus patients during pregn and cardiac functlon ancy.Methods A total of 61 pregnancy cases with SLE were randomly divided into two groups.The 31 cases observation group with hydroxychioroquine plus hormone therapy and 30 cases control group with hormone therapy.The blood lipid, homocysteine and cardiac function change were analyzed in the two groups.Results The observation group total cholesterol(TC), three glycerol(TG),low density lipoprotein cholesterol(LDL-C), high density lipoprotein cholesterol (HDL-C) and homoeysteine (Hcy) were lower than the control group,there was statistical difference between two groups ; Serum Hcy, TC, TG and LDL were positively correlated with SLEDAI score. Serum Hey level was positively correlated with TC,TG and LDL; Heart function between the two groups had no obvious change.Conclusion The patients with systemic lupus erythematosus pregnancy using hydroxychloroquine can significantly improve lipid metabolism, and has little effect on cardiac function. So that patients with SLE using hydroxychloroquine were beneficial during pregnancy, and can effectively improve the glucose and lipid metabolism,reduce the risk of cardiovascular disease and SLEDAI score.
作者 刘恩令 刘铮 周玉秀 田玉荣 冯秀娟 LIU Enling LIU Zheng ZHOU Yuxiu et al(The Department of Obstetrics and Gynecology, Tangshan Gongren Hospital affiliated to Hebei Medical University, Tangshan 063000, Chin)
出处 《华北理工大学学报(医学版)》 2017年第4期277-280,共4页 Journal of North China University of Science and Technology:Health Sciences Edition
基金 河北省科技厅重点研究项目(编号:162777190)
关键词 系统性红斑狼疮 羟氯喹 血脂 同型半胱氨酸 心功能 孕期 Systemic lupus erythematosus. Hydroxychloroquine. Blood lipid. Homocysteine. Heart function.Pregnancy
  • 相关文献

参考文献1

二级参考文献21

  • 1Ruiz-Irastorza G, Ramos-Casals M, Brito-Zeron P, et al. Clinical efficacy and side effects of antimalarials in systemic lupus ery- thematosus: a systematic review[J]. Ann Rheum Dis, 2010, 69: 20-28.
  • 2Willis R, Seif AM, McGwin G Jr, et al. Effect of hydroxych- loroquine treatment on pro-inflammatory cytokines and disease activity in SLE patients: data from LUMINA (LXXV), a multi- ethnic US cohort[J]. Lupus, 2012, 21 : 830-835.
  • 3Akhavan PS, Su J, Lou W, et al. The early protective effect of hydroxychloroquine on the risk of cumulative damage in patients with systemic lupus erythematosus [J]. J Rheumatol, 2013, 40: 831-841.
  • 4Shinjo SK, Bonfa E, Wojdyla D, et al. Antimalarial treatment may have a time-dependent effect on lupus survival: data from a multinational Latin American inception cohort [J]. Arthritis Rheum,2010, 62: 855-862.
  • 5Clowse ME, Magder L, Witter F, et al. Hydroxychloroquine in lupus pregnancy[J]. Arthritis Rheum, 2006, 54: 3640-3647.
  • 6Suarez-Almazor ME, Belseck E, Shea B, et al. Antimalarials for treating rheumatoid arthritis (review)[J/CD]. Cochrane Database Syst Rev, 2000(2) : CD000959.
  • 7Clegg DO, Dietz F, Duffy J, et al. Safety and efficacy of hydrox- ychloroquine as maintenance therapy for rheumatoid arthritis after combination therapy with methotrexate and hydroxychloroquine[J]. J Rheurnatol, 1997, 24: 1896-1902.
  • 8Carmiehael SJ, Beal J, Day RO, et al. Combination therapy with methotrexate and hydroxychloroquine for rheumatoid arthritis increases exposure to methotrexate[J]. J Rheumatol, 2002, 29: 2077-2083.
  • 9O'Dell JR, Left R, Paulsen G. et al. Treatment of rheumatoid arthritis with methotrexate and hydroxychloroquine, methotrexate and sulfasalazine, or a combination of the three medications: results of a two-year, randomized, double-blind, placebo-con- trolled trial[J]. Arthritis Rheum, 2002, 46:1164-1170.
  • 10Singh JA, Furst DE, Bharat A, et al. 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis[J]. Arthritis Care Res (Ho- boken), 2012, 64: 625-639.

共引文献16

同被引文献55

引证文献5

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部